Retrospective analysis of 223 cases of acute cholangitis treated by the recommendations of Tokyo guidelines

Dai-xiang LIAO,Cheng-hua LUO,Bing LI,Jun-hui YU,Zhan-zhi ZHANG,Yan WANG,Cheng-li MIAO
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2013.23.058
2013-01-01
Abstract:Objective To investigate the clinical significance of Tokyo Guidelines for acute cholangitis(AC). Methods 223 patients involved in the study, following the diagnositic criteria and severity assessment and strategy of treatments, were analyzed retrospectively from Oct. in 2006 to Oct. in 2012 in our hospital. Results (1) Following the traditional criteria of Charcot's trid, only 64.1%(143/223) of AC got definite diagnosis at the first time, whereas that was 86.09%(192/223) following the Tokyo Guidelines criteria, but 7.85%of non-AC were misdiagnosed as AC. (2) To assess the severity of AC suggested by Tokyo Guidelines, there were 30.49%(68/223) of mild (gradeⅠ), 55.6% (124/223) of moderate (grade Ⅱ) and 13.9% (31/223) of severe (grade Ⅲ), while only 7.6%(17/223) satisfied sever AC according to Reynold’s Pentad. (3) choledocholithiasis or malignant tumors were the common etiologies, 81.17%(181/223) or 10.77% (24/223), respectively. 95.96%of patients had biliary obstruction, while other 4.14% (9/223) had not biliary dilatation but "accumulative gas sign". (4) Biliary drainage was performed in 63.23% (141/223) of patients. The effective rate of ENBD and PTCD was about 70.45% (62/88). (5) Total mortality was 5.38% (12/223), and 58.33% (7/12) of death were simultaneously concomitant with serious disease in other organs or systems. Conclusion It is more precise to diagnose and evaluate the severity of AC that employing the criteria of Tokyo Guidelines. Furthermore, the strategy of the treatments is very normative and practical. The mortality can be obviously reduced on account of following the recommendations of Tokyo Guidelines. However, it maybe misdiagnose because of false positive.
What problem does this paper attempt to address?